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Introduction: Although the prognostic value of persistent hyperlactatemia in septic shock is unequivocal, its
physiological determinants are controversial. Particularly, the role of impaired hepatic clearance has been underestimated
and is only considered relevant in patients with liver ischemia or cirrhosis. Our objectives were to establish whether
endotoxemia impairs whole body net lactate clearance, and to explore a potential role for total liver hypoperfusion
during the early phase of septic shock.
Methods: After anesthesia, 12 sheep were subjected to hemodynamic/perfusion monitoring including hepatic and
portal catheterization, and a hepatic ultrasound flow probe. After stabilization (point A), sheep were alternatively
assigned to lipopolysaccharide (LPS) (5 mcg/kg bolus followed by 4 mcg/kg/h) or sham for a three-hour study period.
After 60 minutes of shock, animals were fluid resuscitated to normalize mean arterial pressure. Repeated series of
measurements were performed immediately after fluid resuscitation (point B), and one (point C) and two hours later
(point D). Monitoring included systemic and regional hemodynamics, blood gases and lactate measurements, and
ex-vivo hepatic mitochondrial respiration at point D. Parallel exogenous lactate and sorbitol clearances were performed
at points B and D. Both groups included an intravenous bolus followed by serial blood sampling to draw a curve using
the least squares method.
Results: Significant hyperlactatemia was already present in LPS as compared to sham animals at point B (4.7 (3.1 to 6.7)
versus 1.8 (1.5 to 3.7) mmol/L), increasing to 10.2 (7.8 to 12.3) mmol/L at point D. A significant increase in portal and
hepatic lactate levels in LPS animals was also observed. No within-group difference in hepatic DO2, VO2 or O2 extraction,
total hepatic blood flow (point D: 915 (773 to 1,046) versus 655 (593 to 1,175) ml/min), mitochondrial respiration, liver
enzymes or sorbitol clearance was found. However, there was a highly significant decrease in lactate clearance in LPS
animals (point B: 46 (30 to 180) versus 1,212 (743 to 2,116) ml/min, P <0.01; point D: 113 (65 to 322) versus 944
(363 to 1,235) ml/min, P <0.01).
Conclusions: Endotoxemia induces an early and severe impairment in lactate clearance that is not related to total liver
hypoperfusion.* Correspondence: glennguru@gmail.com
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The evolution of serum lactate levels during septic shock
resuscitation represents a balance between aerobic or
anaerobic production, and clearance by different tissues
[1-3]. Clearance is more strictly a pharmacokinetic term
used to describe drug or substance elimination from the
body without identifying the elimination process. The
term ‘lactate clearance’ has somehow been erroneously
used in medical literature when referring to the process
of change in serial lactate levels in response to therapy.
Indeed, a decrease in serum lactate levels could be caused
either by a decreased production or increased clearance,
and the inverse is also true [1-3].
Although the liver plays a major role in systemic lactate
clearance [1], persistent hyperlactatemia has only been
related to impaired hepatic clearance in cases of severe
shock with a comorbidity of liver ischemia or advanced
cirrhosis [4,5]. Unfortunately, there is a large gap of
knowledge in this area due to the relative lack of
comprehensive physiological studies addressing the
role of the liver in hyperlactatemia. In addition, current
experimental and clinical studies provide conflicting data
about liver lactate metabolism during sepsis, irrespective
of the original source of lactate [6-16]. Douzinas et al.
reported net lactate production by the liver in all of 10
stable septic patients with liver dysfunction [6], whereas
De Backer et al. observed this in only 7% of 90 septic
patients [7]. Levraut et al. evaluated whole body net
lactate clearance and production in 34 stable septic
patients with normal to mildly elevated lactate levels by a
bolus infusion of L-lactate [9]. Patients with elevated
baseline lactate levels exhibited approximately 50%
lower lactate clearance. Others have stressed a dynamic
relationship between arterial and/or portal lactate
levels, and hepatic lactate uptake [17]. In addition,
hepatic lactate metabolism might even be a saturable
process [18], influenced by pH [19-21], substrate
availability [13,22], and sepsis [1,11]. Part of these
conflicting results could be explained by the extreme
variability in the design of both experimental and
clinical studies [6-16]. Nevertheless, common opin-
ion suggests a significant role for hepatic dysfunction
in delayed lactate clearance. If liver perfusion is
shown to be a major component in delayed lactate
clearance, this could have particularly significant clinical
implications.
To address this, we designed a short-term controlled
physiological study in a well-standardized sheep model
of endotoxic shock, which characteristically evolves into a
hyperdynamic hyperlactatemic profile after resuscitation
[23]. Our objectives were to establish if endotoxemia
impairs whole body net lactate clearance, and to explore a
potential role for total liver hypoperfusion during the early
phase of septic shock.Methods
The study was performed at the Medical Research Center
of the School of Medicine, Pontificia Universidad Católica
de Chile, as part of a major project exploring the influence
of adrenergic stimulation and blockade over the determi-
nants of lactate production and utilization in endotoxic
shock (FONDECYT Chile grant number 1130200). The
study was performed in accordance with the National
Institutes of Health Guide for the Care and Use of Labora-
tory Animals, and with the approval of the Comité de Etica
y Bienestar Animal of our University (CEBA 12-031).
Anesthesia and surgery
Anesthesia
Sheep (weight: 29 to 41 kg) were received at the Research
Center, and fasted for 24 hours before surgery, except for
free water access. Sheep were premedicated with 20 mg/kg
ketamine and 0.25 mg/kg midazolam intramuscularly.
After inserting a peripheral intravenous line and injecting
30 mcg/kg fentanyl + 0.5 mg/kg atracurium + 1 mg/kg
lidocaine intravenously, sheep were intubated and
connected to mechanical ventilation. Anesthesia was
maintained with a continuous infusion of 2 mg/ml
midazolam, 20 mcg/ml fentanyl, and 20 mg/ml ketamine,
set at 0.5 ml/kg/h during invasive procedures, and at
0.25 ml/kg/h thereafter until the end of the experiment.
Muscle paralysis was maintained with a continuous infu-
sion of 0.25 mg/kg/h atracurium throughout the experi-
ment. Animals were ventilated with a volume-controlled
ventilator (Dräger Evita XL®, Lübeck, Germany) with 8 cm
H2O end-expiratory pressure. The fraction of inspired
oxygen (FiO2) was adjusted to keep oxygen tension (pO2)
levels between 100 and 150 mmHg. Tidal volume was kept
at 10 ml/kg and minute ventilation adjusted to maintain
partial oxygen pressure (PaCO2 (partial pressure of carbon
dioxide)) levels between 35 and 45 mmHg. Throughout the
experiment, carbon dioxide was monitored with a main-
stream end-tidal CO2 detector (Philips Medical Systems,
Eindhoven, The Netherlands). Throughout the surgical pro-
cedure, the animals received normal saline at 10 ml/kg/h.
The body temperature of the animals was kept at 38 ± 0.5°C.
Surgery
An 8Fr sheath was placed in the left and right external
jugular veins for subsequent placement of a pulmonary
artery catheter and a hepatic vein catheter, respectively
(the latter was placed in an accurate position with intra-
abdominal ultrasound guidance). The left femoral artery
and vein were surgically exposed, and an arterial catheter
and a three-lumen central venous catheter were inserted
for blood pressure monitoring, sampling, and infusions.
Then, a midline laparotomy was performed, followed by a
gastrostomy to allow drainage of gastric contents and a
splenic vein ligature. Afterwards, the hepatic artery and
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sound flow probe (Transonic®, Ithaca NY, USA) was
placed around both vessels to assess total hepatic flow.
Another catheter was inserted into the portal vein and
then the laparotomy was closed. After surgery, the saline
infusion was reduced to 5 ml/kg/h and maintained till the
end of the experiment.
Measurements
Several measurements were performed at different time
points as described below.
1. Hemodynamic data extraction: Femoral and
pulmonary arterial, central venous, and pulmonary
capillary wedge pressures were recorded with quartz
pressure transducers displayed on a multi-modular
monitor (Datex- Engström®, Madison WI, USA). All
pressure transducers were calibrated and zeroed at
mid-chest level and obtained at end-expiration.
Cardiac output (CO, L/min) was measured by a
thermodilution technique (mean value of three
measurements, CO module, Datex-Engström®,
Madison WI, USA). Central venous blood
temperature was recorded from the thermistor in the
pulmonary artery catheter. Heart rate was measured
from the electrocardiogram. Hemodynamic data were
recorded every 30 minutes.
2. Systemic and hepatosplanchnic oxygen delivery,
consumption, and lactate handling: Arterial, portal,
hepatic vein, mixed venous, and central venous
gases were measured with a blood gas analyzer
(i-Stat® bedside gas analyzer, Princeton NJ, USA).
Total hepatic blood flow was recorded with an
ultrasound flow probe involving the hepatic artery
and portal vein (Transonic®, Ithaca NY, USA).
Systemic and hepatic oxygen delivery, consumption,
and extraction were calculated according to standard
formulas, which are summarized in Additional file 1.
3. Lactate assessment: Lactate concentrations at each
experimental time point obtained from arterial and
venous blood samples were determined directly by
lactate scout monitor (Senslab®, Leipzig, Germany).
We performed the measurements in triplicate and
averaged results.
4. Lactate clearance: This technique was performed twice
during the experiment. A bolus infusion of sodium
L-lactate (1 mmol/kg, in a 50 ml saline solution) was
infused via a central venous catheter over 15 minutes.
Arterial lactate blood samples were taken at baseline
and 1, 3, 6, 9, 15, and 20 minutes after the lactate
bolus, and measured with the lactate scout monitor in
triplicate (Senslab, Leipzig, Germany). Clearance was
later analyzed using the least squares method with
semi-logarithmic coordinates [9].5. Sorbitol clearance: This technique was performed
twice during the study since it has been proposed to
indirectly assess liver blood flow due to its very high
first pass liver extraction [24]. A bolus of D-sorbitol
(30 mg/kg, 5% solution in saline buffer) was infused
via a central venous catheter over one minute.
Arterial blood samples were taken at baseline and 1,
3, 9, and 15 minutes after infusion, and immediately
frozen. Sorbitol levels were measured later by the
enzymatic method coupled to formazan formation
according to the manufacturer directions (Biovision®,
Milpitas CA, USA). Assessment of sorbitol clearance
was similar to that of lactate clearance [9]
6. Mitochondrial respiration: This technique was used
to assess functional vitality of liver mitochondria at
the end of the experiment. Liver samples were taken
at the end of the experiment and immediately put
on cold phosphate buffered saline. Complex I- and
II-dependent respiration rates were measured using
high-resolution respirometry (Oxygraph-2 k®;
Oroboros Instruments, Innsbruck, Austria), and
are expressed as pmol/second/mg whole protein
content. Active respiration after addition of
adenosine diphosphate (ADP) (State 3) was
measured using glutamate/malate and succinate as
substrates for complex I and II, respectively [25].
Experimental procedure
After one hour of post-surgery stabilization, basal mea-
surements were recorded (Figure 1, point A). Sheep were
then alternatively assigned to either the endotoxin
(lipopolysaccharide (LPS); n = 6) or sham (n = 6) group. In
the protocol animals, sepsis was induced by a 5 mcg/kg
endotoxin bolus (Escherichia coli 0111:β4; Sigma, St Louis
MO, USA) given in 1 minute, followed by a continuous
infusion of 4 mcg/kg/h during the rest of the experiment.
Control animals were infused with saline. During the first
hour of endotoxin or placebo infusion no other fluid was
administered. Thereafter, resuscitation was performed with
5 ml/kg saline boluses repeated up to 3 times until a mean
arterial pressure (MAP) target of 55 to 60 mmHg or a pulse
pressure variation under 10% was achieved. If fluid loading
failed to restore MAP to target levels norepinephrine was
started. Repeated series of measurements were performed
after fluid resuscitation (point B), and one and two hours
later (Figure 1, points C and D, respectively).
At each time point hemodynamic and respiratory vari-
ables, blood temperature, hepatic blood flow, and arterial,
mixed, central venous, portal, and hepatic vein blood
gases and lactate samples were taken simultaneously.
Samples for liver enzymes were taken, and sorbitol and
lactate clearances performed at points A, B, and D.
Following completion of the experiment, a liver biopsy for
study of mitochondrial function was taken.
Figure 1 General scheme of the protocol. Complete hemodynamic, respiratory, and systemic and regional perfusion assessment was performed
at points A, B, C, and D, except for lactate and sorbitol clearances that were done only at points A, B, and D. hr, hour; LPS, lipopolysaccharide.
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Non-parametric tests were used since data exhibited a
non-normal distribution. Results are expressed as median
and interquartile range. Intra-group medians were
compared with Friedman’s test and Bonferroni’s post-hoc
correction. Inter-group medians were compared by
Mann–Whitney U test. SPSS software version 17.0
(Chicago, IL, USA) was used for statistical calculations.
P <0.05 was considered as statistically significant. All
reported P values are two-sided.
Results
LPS induced a hemodynamic profile of septic shock
with significant hypotension and pulmonary hyper-
tension, and a trend of increased CO (Table 1). All
LPS animals required norepinephrine in progressively
higher doses up to 2.43 (2.2 to 2.7) mcg/kg/min at
point D. A significant hyperlactatemia was already
present in LPS as compared to sham animals (4.7
(3.1 to 6.7) versus 1.8 (1.5 to 3.7) mmol/L) following
fluid resuscitation (point B), increasing to 10.2 (7.8
to 12.3) mmol/L at the end of the experiment (point D)
(Table 2).
Portal and hepatic vein lactate levels were significantly
higher in the LPS animals at different time points and
tended to increase over time (Table 3). Analysis of
portohepatic vein lactate differences showed very low
extraction rates (point B: portal lactate 4.0 and hepatic
vein lactate 4.1 mmol/L; point C: portal lactate 6.4,
hepatic vein lactate 6.1 mmol/L; point D: portal lactate
8.3, hepatic vein lactate 7.3 mmol/L; Table 3).
When comparing intergroup values at any time point,
no differences in hepatic DO2, VO2, and O2 extraction,
total hepatic blood flow, or in hepatic vein or portal oxygen
saturations were detected, except for portal O2 saturation
at point D (Table 3). However, hepatic DO2, total hepatic
blood flow, and fractional hepatic blood flow tended
to decrease over time in LPS animals.Aminotransferases, bilirubin (Br), and gamma-glutamyl
transferase (GGT) were comparable between sham and
LPS animals at the end of the experiment (alanine amino-
transferase (ALT): 16 (15 to 17) versus 20 (15 to 30) U/L;
aspartate aminotransferase (AST): 144 (124 to 162) versus
264 (204 to 277) U/L; Br: 0.09 (0.07 to 0.09) versus
0.09 (0.08 to 0.1) mg/dl; GGT: 49 (39 to 51) versus
64 (50 to 83) U/L). Mitochondrial respiration was not
different between groups (basal: sham 66 (47 to 88),
LPS 27 (17 to 41); complex I: sham 450 (113 to 524), LPS
206 (160 to 248); complex I + II: sham 644 (324 to 719),
LPS 350 (304 to 471) pmol/sec/mg).
Sorbitol clearance at points A, B, and D was preserved
in both LPS and sham animals. Following the induction of
shock (point B), lactate clearance decreased significantly
in the LPS animals without recovery at the end of the
experiment (point D, Table 2, Figure 2).
Discussion
Our results demonstrate that endotoxic shock induces a
very early and severe impairment in exogenous whole
body net lactate clearance that is not related to total
liver hypoperfusion or evident biochemical dysfunction.
However, the very low portohepatic vein lactate differences
suggest at least a liver metabolic inability to handle in-
creased lactate loads. This appears to be a specific rather
than generalized metabolic dysfunction in LPS animals as
the clearance of sorbitol, a polyol molecule with a 96% first
pass liver extraction, was preserved. This finding might
lead to reconsider the role of the liver in persistent hyper-
lactatemia, and opens new perspectives for translational
and clinical research on a complex potential resuscitation
target, such as lactate.
To assess lactate clearance we used the method proposed
by Levraut et al. [9]. Whole body net lactate clearance and
lactate production were evaluated in 34 stable septic
patients with normolactatemia or mild hyperlactatemia by
modeling the lactate kinetics induced by an exogenous
Table 1 Hemodynamic and respiratory variables in sham versus LPS animals
Variable Group A B C D Pa
HR (bpm) Sham 146 (111–169) 149 (117–180) 137 (122–161) 146 (127–159) 0.78
LPS 133 (107–163) 152 (128–164) 147 (123–150) 127 (113–142) 0.12
MAP (mmHg) Sham 81 (64–99) 85 (70–108) 87 (73–100) 68 (58–82) 0.13
LPS 92 (79–103) 59 (56–80)b 57 (57–62)b 63 (56–75) 0.08
CO (L/min) Sham 2.2 (1.9-2.6) 2.4 (2.2-2.9) 2.5 (2.1-3.0) 1.9 (1.6-2.6) 0.10
LPS 2 (1.8-3.1) 3 (2.8-4.7) 3.1 (2.2-3.8) 2.8 (2.2-3.4) 0.18
MPAP (mmHg) Sham 11 (10–13) 12 (10–13) 11 (10–112) 11 (8–11) 0.15
LPS 13 (13–15)b 19 (14–22)b 18 (16–26)b 18 (16–29)b 0.07
PAOP (mmHg) Sham 5 (4–6) 4.5 (4–5) 3.5 (3–6) 4 (3–5) 0.80
LPS 8 (5–9) 8 (6–9) 8 (7–8)b 8 (7–8)b 0.56
Minute ventilation (L/min) Sham 5.7 (5.2-6.4) 5.7 (4.8-6.4) 5.8 (4.8-6.6) 5.0 (4.4-6) 0.17
LPS 5.9 (5.6-6.4) 6.2 (5.5-6.9) 6.3 (5.5-7.6) 6.5 (5.8-7.7)b 0.35
Plateau pressure (mmHg) Sham 21 (18–22) 21 (20–23) 23 (19–25) 22 (21–23) 0.40
LPS 19 (18–22) 24 (20–27) 24 (21–29) 25 (22–28) 0.02
RR (bpm) Sham 16 (15–17) 16 (14–17) 16 (14–17) 16 (14–16) 0.80
LPS 17 (16–19) 19 (16–19) 19 (16–22) 19 (16–22) 0.21
DO2 (ml O2/min) Sham 260 (137–343) 290 (255–419) 270 (266–373) 214 (195–334) 0.06
LPS 224 (203–337) 277 (235–364) 221 (167–358) 203 (158–290) 0.18
VO2 (ml O2/min) Sham 97 (58–132) 99 (83–106) 94 (74–111) 85 (62–96) 0.06
LPS 67 (54–86) 64 (56–75) 63 (53–76) 67 (59–85) 0.80
O2ER (%) Sham 0.33 (0.25-0.37) 0.29 (0.25-0.4) 0.29 (0.25-0.41) 0.31 (0.26-0.47) 0.56
LPS 0.28 (0.24-0.31) 0.24 (0.17-0.30) 0.30 (0.18-0.36) 0.35 (0.25-0.42) 0.17
SvO2 (%) Sham 69 (65–74) 67 (63–74) 70 (60–75) 68 (55–75) 0.32
LPS 77 (70–78) 76 (67–84) 68 (61–84) 65 (54–77) 0.09
CO, cardiac output; DO2, oxygen delivery; HR, heart rate; LPS, lipopolysaccharide; MAP, mean arterial pressure; MPAP, mean pulmonary arterial pressure; O2ER,
oxygen extraction rate; PAOP, pulmonary artery occlusion pressure; RR, respiratory rate; SvO2, mixed venous oxygen saturation; VO2, oxygen consumption. Values
are presented as median (interquartile range). P <0.05 considered as significant. aSignificant changes over time within groups. Comparison made with Friedman’s
test and Bonferroni’s post-hoc correction. bSignificant difference between groups at the same time point. Comparison made with Mann–Whitney U test.
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to normolactatemic patients exhibited approximately 50%
lower lactate clearance after the challenge. In the current
study, lactate clearance decreased by more than 90% in LPS
animals. This dramatic decrease in clearance was observed
very early after LPS administration (a mean of 80 minutes
after initial bolus of LPS) and was not restored by systemicTable 2 Evolution of serum lactate, sorbitol, and lactate clear
Variable Group A B
Arterial lactate (mmol/L) Sham 2.4 (1.5-4.3) 1
LPS 2.8 (2–3.6) 4
Sorbitol clearance (ml/min) Sham 582 (327–739) 3
LPS 481 (354–506) 5
Lactate clearance (ml/min) Sham 1,299 (418–2,187) 1
LPS 1,066 (108–1,660) 4
Values are presented as median (interquartile range). P <0.05 considered as signific
Friedman’s test and Bonferroni’s post-hoc correction. bSignificant difference between
LPS, lipopolysaccharide.resuscitation. Thus, impaired lactate clearance develops
very early in septic shock, varies in severity according to the
magnitude of the septic insult, and persists over time
considering that 12 out of 34 patients in Levraut’s study [9]
were studied after three days of septic shock. Additionally,
liver biochemistry was almost normal in both studies,
suggesting a selective metabolic dysfunction not easilyances at different time points
C D Pa
.8 (1.5-3.7) 2.2 (1.8-4.7) 2 (1.8-3.3) 0.8
.7 (3.1-6.7)b 7.1 (5.1-9.4)b 10.2 (7.8-12.3)b 0.01
85 (221–1,060) NA 453 (348–612) 0.5
19 (333–578) NA 581 (318–824) 0.23
212 (743–2,116) NA 944 (363–1,235) 0.60
6 (30–180)b NA 113 (65–322)b 0.01
ant. aSignificant changes over time within groups. Comparison made with
groups at the same time point. Comparison made with Mann–Whitney U test.
Table 3 Evolution of hepatosplanchnic flow and perfusion parameters at different time points
Variable Group A B C D Pa
SpO2 (%) Sham 86 (74–90) 86 (76–91) 79 (76–85) 78 (74–89) 0.64
LPS 85 (75–91) 81 (75–86) 76 (65–85) 66 (53–72)b 0.08
ShO2 (%) Sham 73 (62–87) 69 (65–80) 75 (64–81) 72 (55–84) 0.43
LPS 77 (69–80) 75 (72–84) 71 (63–73) 68 (46–80) 0.25
Portal lactate (mmol/L) Sham 1.2 (0.6-2.2) 2.2 (1.1-3.8) 1.8 (0.9-3.5) 1.3 (1.1-2.9) 0.31
LPS 2.6 (2.0-3.8)b 4 (3.3-6.3)b 6.4 (5.8-8.2)b 8.3 (7–9.5)b 0.06
Hepatic lactate (mmol/L) Sham 1.3 (0.6-3.1) 1.9 (0.8-3.8) 1.6 (1.1-2.8) 1.2 (1–2.5) 0.52
LPS 2.1 (1.6-2.9) 4.1 (3.3-6.3)b 6.1 (5.1-7.7)b 7.3 (6.4-8.6)b 0.04
Hepatic DO2 (ml O2/min) Sham 117 (53–150) 107 (50–160) 93 (55–128) 88 (42–150) 0.10
LPS 98 (68–133) 97 (75–110) 76 (52–88) 56 (36–70) 0.03
Hepatic VO2 (ml O2/min) Sham 34 (16–49) 28 (13–45) 34 (10–41) 38 (13–41) 0.21
LPS 20 (11–34) 24 (20–30) 28 (17–37) 22 (19–25) 0.7
Hepatic O2ER (%) Sham 0.33 (0.25-0.37) 0.33 (0.19-0.45) 0.46 (0.30-058) 0.34 (0.22-0.59) 0.81
LPS 0.25 (0.10-0.35) 0.22 (0.20-0.34) 0.37 (0.32-0.44) 0.42 (0.30-0.73) 0.34
Total hepatic blood flow (ml/min) Sham 707 (585–1,335) 770 (660–1,250) 732 (673–1,213) 655 (593–1,175) 0.40
LPS 1,150 (753–1,568) 1,275 (1,181-1,700) 1,050 (880–1,227) 915 (773–1,046) 0.048
Fractional hepatic blood flow (%) Sham 47 (32–62) 41 (34–47) 39 (30–48) 46 (35–57) 0.43
LPS 50 (43–56) 41 (39–44) 35 (31–43) 32 (26–43)b 0.08
Hepatic DO2, hepatic oxygen delivery; Hepatic O2ER, hepatic oxygen extraction rate; Hepatic VO2, hepatic oxygen consumption; ShO2, hepatic vein oxygen
saturation; SpO2, portal vein oxygen saturation.
Values are presented as median (interquartile range). P <0.05 considered as significant. aSignificant changes over time within groups. Comparison made with
Friedman’s test and Bonferroni’s post-hoc correction. bSignificant difference between groups at the same time point. Comparison made with Mann–Whitney U test.
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functional tests.
The liver is the primary organ involved in lactate
clearance, accounting for approximately 50% of uptake
[1]. L-lactate is taken up by the hepatocyte mainly via a
monocarboxylate carrier, and it is metabolized within the
hepatocytes by oxidation or as a substrate for neogluco-
genesis. Total hepatic blood flow is critical in this process,
but the relationship between flow and lactate clearance is
controversial [6,7,9,16]. Although hepatic lactate extrac-
tion decreases during low flow states without sepsis, this
occurs only after dramatic decreases in flow [17,26,27].
Samsel et al. studied eight pump-perfused canine livers
and demonstrated that lactate clearance decreases
only when a critical O2 delivery is reached [17]. Iles et al.
observed that lactate uptake decreases rapidly when
blood flow falls below 25% of normal in an isolated
rat liver model [26]. Tashkin et al. confirmed that this
does not occur under moderate flow reductions where
hepatic lactate uptake can respond with a compensatory
increase [27].
Although under normal conditions there is a large
metabolic reserve in hepatic lactate metabolism that
may compensate for moderate reductions in flow as
stated above, this may not be the case in pathological
conditions such as sepsis. Chrusch et al. observed thatlactate extraction after an exogenous lactate loading was
only 3.6% in septic animals as compared to 14.9% in
non-septic controls [19]. Pscheidl et al. used radioactive
microspheres to assess changes in regional blood flow
during low-dose LPS infusion in a rat model [28]. They
found decreased portal flow that was compensated by
the hepatic arterial buffer response, thus maintaining
total hepatic flow. Nevertheless, lactate clearance decreased
significantly despite this preserved flow [28]. Santak et al.
found a persistent increase in total hepatic flow in LPS
versus control animals in a long-term pig endotoxin shock
model, but lactate clearance decreased progressively for up
to 24 hours [16]. Our results are in line with these previous
studies, with some new aspects highlighted below.
However, there are some contrasting data. Severin et al.
applied a bolus LPS dose of 6 mcg/kg in a chronically
catheterized rat model [15]. The hemodynamic effect was
modest, with a minor increase in lactate from 0.84 to
2.7 mmol/L at 120 minutes. Interestingly, the liver
increased lactate extraction as suggested by a negative
shift in the hepatic vein to portal vein lactate concentra-
tion gradient [15]. Bellomo et al. found no correlation
between hepatic lactate uptake and liver oxygen transport,
consumption, or extraction in a dog endotoxic model
[11]. Creteur et al. performed one of the most relevant
studies in 18 anesthetized dogs receiving a very high dose
Figure 2 Evolution of total hepatic blood flow. (A), sorbitol (B) and lactate clearances (C) at different time points in sham versus LPS animals. As
shown, no differences were detected in flow or sorbitol clearances, but there was a highly significant decrease in lactate clearance in LPS animals
at points B and D. Bars represent median (interquartile range). *P <0.05, comparison made with Mann–Whitney U test. LPS, lipopolysaccharide.
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dynamic cardiac tamponade to induce a hypodynamic state
with progressive reductions in hepatic blood flow. These
animals experienced decreased liver lactate extraction
below a critical oxygen delivery rate. The other six septic
dogs experienced increased gut lactate production, but this
was compensated by a huge increase in liver lactate uptake,
and thus whole hepatosplanchnic lactate production
remained stable [29].
Eventually, these confounding data may be explained
by the extreme heterogeneity of experimental studies
addressing lactate handling during septic shock in
terms of model (intravenous bolus, intraperitoneal, or con-
tinuous infusion of LPS; or cecal ligation and puncture),
observation periods, resuscitation strategies, and techniques
to assess flow, among others. Very few models have repro-
duced the characteristic post-resuscitative hyperdynamic
septic shock in humans as in our study.
Hepatosplanchnic hypoperfusion has been traditionally
considered as an important mechanism during septic
shock leading to bacterial or endotoxin translocation,
and to impairment of several aspects of liver function,
among other consequences [12]. However, regional
perfusion is difficult to assess, even in the experimental
setting. In our study we complemented direct flow mea-
surements, O2 delivery, and extraction assessments, with
D-sorbitol clearance [24]. D-sorbitol has a high liver
extraction ratio and its clearance is dependent on delivery
to the hepatocytes by hepatic blood flow. Therefore, the
rate of plasma clearance of sorbitol can be used as a meas-
ure of liver blood flow and function [24]. In our experi-
ment, we did not find hepatic hypoperfusion or hypoxia, as
total hepatic blood flow, sorbitol clearance, hepatic DO2,
VO2 and O2 extraction, hepatic vein oxygen saturation,
and liver O2 extraction, ex-vivo mitochondrial respiration,
and liver enzymes, such as aminotransferases normally
released during hepatic ischemia, were comparable
between LPS and sham groups. Only at the end of
the experiment did hepatic blood flow and eventually
mitochondrial respiration decrease in LPS animals.
Therefore, we cannot rule out that hypoperfusion
may play a role in a more prolonged model. However,
the highly significant impairment in clearance as early
as at point B without a significant change in total
hepatic blood flow at this point precludes hypoperfusion
from being an important factor, at least in early stages
after fluid resuscitation.
Our study introduced new methodological aspects
such as a more exhaustive assessment of potential overt
or occult liver hypoperfusion, a more clearly defined
resuscitation protocol, and simultaneous evaluation of
lactate and sorbitol clearances. In this study, the decrease
in whole body net lactate clearance was clearly out of
proportion with systemic and regional hemodynamics,and was present in absence of traditional biochemical
evidence of liver injury or other metabolic dysfunctions,
such as with sorbitol uptake. However, the very low
portohepatic vein lactate differences suggest at least a
liver metabolic inability to handle increased lactate
loads, and thus an acquired metabolic dysfunction or
shift. Thus, it appears that a relevant specific metabolic
liver dysfunction without clear clinical expression can
occur during septic shock resuscitation even with pre-
served hemodynamics, and this could have a significant
impact on lactate clearance.
Several factors could explain these findings. First,
several studies have suggested that endotoxin or pro-
inflammatory mediators may inactivate pyruvate dehydro-
genase or phosphoenolpyruvate carboxykinase enzymes,
thus potentially blocking two metabolic pathways for lactate
metabolism [30,31]. Second, hepatic lactate uptake might
be a saturable process with second order kinetics [18].
Therefore, repeated exogenous lactate loading over a short
period could lead to lactate accumulation by saturating
metabolic clearance. However, the same loading in sham
animals did not produce any accumulation, suggesting that
a metabolic dysfunction should be present for this to occur.
Third, impairment in hepatic microcirculation might be
implicated [32-35]. Doubtlessly, severe liver microcircula-
tory abnormalities can be found in the presence of normal
total hepatic flow. Either portal or hepatic arterial LPS
injection leads to a rapid and transient increase in
intrahepatic resistances at the presinusoidal level
[31-35]. Redistribution of intrahepatic blood flow in
concert with a complex interplay between sinusoidal
endothelial cells, liver macrophages, and passing leuko-
cytes, leads to a decreased perfusion and blood flow
velocity in the liver sinusoids [31-35]. Activation and
dysfunction of the endothelial cell barrier, together with
abnormalities in the nitric oxide pathway, with subse-
quent invasion of neutrophils and formation of micro-
thrombi may further enhance liver tissue ischemia
and damage [31-35]. Unfortunately, we did not specifically
assess hepatic microcirculation. However, preserved liver
VO2 and normality of ex-vivo mitochondrial respiration,
taken together with the absence of positive portohe-
patic vein lactate gradients, makes it unlikely that this
phenomena had some impact in lactate clearance.
Fourth, local production of lactate by activated
immune cells in the liver during sepsis is another
biologically plausible cofactor [11,36]. Theoretically, the
impact on local lactate production could be propor-
tional to the inflammatory stimulus, and thus might
change according to the experimental model selected.
Unfortunately, our study design only allowed us to
address some of these potential mechanisms, but we were
able to rule out liver hypoperfusion or a generalized
metabolic dysfunction.
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we did not assess renal uptake of lactate, which is an
important omission since the kidneys are second only to
the liver in lactate clearance after an external lactate load
[1]. Second, we did not quantitatively assess metabolic
handling by the liver. Third, we did not assess hepatic
microcirculation. Fourth, repeated lactate loads over a
short period of time may have saturated liver metabolic
capacity, thus introducing bias. However, the strengths
of the study shows that we reproduced a hyperdynamic
septic shock in a large animal model closely resembling
human cases. We assessed liver perfusion more compre-
hensively than previous studies and can effectively rule
out the presence of hypoperfusion or hypoxia. We also
demonstrated a severe impairment of lactate clearance
very early after endotoxin infusion, despite normal
clinical liver biochemistry and other metabolic functions.
Finally, we demonstrated that this process persists over
time, even while maintaining systemic hemodynamics.
Of course, our findings cannot be extrapolated to low flow
states or hypodynamic shock, where liver hypoperfusion
can induce a decrease in lactate clearance.
The results of our study might have relevant clinical
implications. Although tissue hypoperfusion has been
traditionally considered an important cause of persistent
hyperlactatemia, there is increasing evidence for con-
comitant non-hypoxic, and thus, non-flow-dependent
mechanisms such as hyperadrenergia or subclinical
sepsis-induced liver metabolic dysfunction, that may in-
fluence the time course of lactate recovery rate [2]. The
distinction between these two scenarios should strongly
impact the therapeutic approach. As an example,
treatment of the latter with sustained efforts aimed at
increasing DO2 could lead to severe resuscitation toxicity
expressed as fluid overload, pulmonary edema, or intraab-
dominal hypertension, with no therapeutic benefit if the
impaired lactate clearance is caused by a non-hypoxic
liver dysfunction irrespective of the involved intimate
pathogenic mechanisms. This is true even if lactate
clearance is a saturable biochemical process. These
considerations should not lead to a therapeutic nihilism
concerning lactate. Hyperlactatemia is still a very strong
prognostic factor. The above statements only pretend
to highlight the relevance of trying to establish the
cause of the problem before automatically prescribing
fluids or additional resuscitation, since not all causes of
hyperlactatemia are flow-sensitive [2,37].
Conclusions
In conclusion, our results demonstrate that hyperdynamic
endotoxic shock induces an early, and severe, impairment
in lactate clearance that is not related to total liver hypo-
perfusion or evident biochemical dysfunction. This finding
might have relevant clinical implications and should leadto further research to clarify the role of the liver in lactate
handling during septic shock resuscitation.
Key messages
 Endotoxemia induces an early and severe
impairment in exogenous whole body net lactate
clearance.
 This profound alteration is not related to liver
hypoperfusion or other evident biochemical
dysfunction.
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